Applied UV, Inc. (NASDAQ:AUVI), an infection prevention technology company that applies the power of narrow-range ultra violet light (“UVC”) to destroy pathogens safely, thoroughly, and automatically, announced late last month the underwriters of its 10.5% Series A Cumulative Perpetual Preferred Stock exercised in full their over-allotment option to purchase an additional 72,000 shares of Series A…
This content is viewable by members only. Visit MY ACCOUNT on the top menu to log in or to register for a 30 day free trial or purchase a subscription for UV Reporter 1 Year Single Membership or UV Reporter 1 Year Group Membership - $189 for first member and $25 for each additional member.
